Champions Oncology (CSBR) Depreciation and Depletion (2010 - 2020)

Champions Oncology's Depreciation and Depletion history runs 11 years deep, the most recent figure standing at $254000.0 for Q4 2020.

• In Q4 2020, Depreciation and Depletion rose 56.79% year-over-year to $254000.0; the TTM figure through Oct 2020 stood at $295000.0 (up 49.75% YoY), while the FY2025 annual figure was $150000.0, up 2.74% from the prior year.
• Depreciation and Depletion was $254000.0 for Q4 2020 at Champions Oncology, up from $224000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $254000.0 in Q4 2020 to a low of -$367000.0 in Q2 2020.
• Historically, Depreciation and Depletion has averaged $63117.6 across 5 years, with a median of $98000.0 in 2018.
• The sharpest annual moves came in 2018 and 2020: Depreciation and Depletion surged 208.33% in 2018, then tumbled 54.85% in 2020.
• A 5-year view of Depreciation and Depletion shows it stood at $34000.0 in 2016, then soared by 144.12% to $83000.0 in 2017, then soared by 38.55% to $115000.0 in 2018, then surged by 40.87% to $162000.0 in 2019, then soared by 56.79% to $254000.0 in 2020.
• The last three Depreciation and Depletion figures came in at $254000.0 (Q4 2020), $224000.0 (Q3 2020), and -$367000.0 (Q2 2020), per Business Quant data.